Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract

被引:12
作者
Nee, J.
Rangan, V.
Lembo, A. [1 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
关键词
constipation; dysmotility; opioids; CHRONIC NONCANCER PAIN; NARCOTIC BOWEL SYNDROME; RANDOMIZED CONTROLLED-TRIAL; INDUCED CONSTIPATION; EMERGING TREATMENTS; CLINICAL-FEATURES; NONMALIGNANT PAIN; DOUBLE-BLIND; MORPHINE; NALOXONE;
D O I
10.1111/nmo.13367
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The use of opioid medications for acute and chronic pain has increased significantly in the past 20 years in the United States. Given the high density of opioid receptors in the gastrointestinal tract, side effects are common in these patients including constipation, dysphagia, bloating, nausea, and vomiting. These side effects, which are experienced by most patients who take opioids, can lead to significant impairment in quality of life. Unlike other side effects from opioids, gastrointestinal side effects do not diminish with continued use, often leading patients to reduce or discontinue their opioid treatment to relieve these side effects. Therefore, physicians must be aware and anticipate potential side effects in patients receiving opioids to ensure appropriate pain management.
引用
收藏
页数:4
相关论文
共 55 条
[1]   Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation [J].
Argoff, Charles E. ;
Brennan, Michael J. ;
Camilleri, Michael ;
Davies, Andrew ;
Fudin, Jeffrey ;
Galluzzi, Katherine E. ;
Gudin, Jeffrey ;
Lembo, Anthony ;
Stanos, Steven P. ;
Webster, Lynn R. .
PAIN MEDICINE, 2015, 16 (12) :2324-2337
[2]   Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract [J].
Bagnol, D ;
Mansour, A ;
Akil, H ;
Watson, SJ .
NEUROSCIENCE, 1997, 81 (02) :579-591
[3]   Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation [J].
Camilleri, M. ;
Drossman, D. A. ;
Becker, G. ;
Webster, L. R. ;
Davies, A. N. ;
Mawe, G. M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (10) :1386-1395
[4]   Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits [J].
Camilleri, Michael ;
Lembo, Anthony ;
Katzka, David A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (09) :1338-1349
[5]   Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain [J].
Chey, William D. ;
Webster, Lynn ;
Sostek, Mark ;
Lappalainen, Jaakko ;
Barker, Peter N. ;
Tack, Jan .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25) :2387-2396
[6]   Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study [J].
Choung, Rok Seon ;
Locke, G. Richard, III ;
Zinsmeister, Alan R. ;
Schleck, Cathy D. ;
Talley, Nicholas J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (05) :1199-1204
[7]   A comparison of the effects of intravenous tramadol, codeine, and morphine on gastric emptying in human volunteers [J].
Crighton, IM ;
Martin, PH ;
Hobbs, GJ ;
Cobby, TF ;
Fletcher, AJP ;
Stewart, PD .
ANESTHESIA AND ANALGESIA, 1998, 87 (02) :445-449
[8]   A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain [J].
Cryer, Byron ;
Katz, Seymour ;
Vallejo, Ricardo ;
Popescu, Anca ;
Ueno, Ryuji .
PAIN MEDICINE, 2014, 15 (11) :1825-1834
[9]  
Drossman Douglas, 2014, Am J Gastroenterol Suppl, V2, P22, DOI 10.1038/ajgsup.2014.6
[10]   Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV [J].
Drossman, Douglas A. .
GASTROENTEROLOGY, 2016, 150 (06) :1262-+